Regression of Experimental Iris Neovascularization with Systemic Alpha-interferon
- 1 January 1993
- journal article
- Published by Elsevier in Ophthalmology
- Vol. 100 (1) , 9-14
- https://doi.org/10.1016/s0161-6420(93)31712-4
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Phthalocyanine Photodynamic Therapy of Experimental Iris NeovascularizationOphthalmology, 1991
- Interferon Alpha 2a For Treatment of Age-Related Macular DegenerationAmerican Journal of Ophthalmology, 1991
- Cytokines and endothelial cell biologyPhysiological Reviews, 1990
- TREATMENT OF HAEMANGIOENDOTHELIOMAS WITH ALPHA INTERFERONThe Lancet, 1989
- Treatment of Pulmonary Hemangiomatosis with Recombinant Interferon Alfa-2aNew England Journal of Medicine, 1989
- Successful Treatment of an Angiogenic DiseaseNew England Journal of Medicine, 1989
- Extracellular Modulating Factors and the Control of Intraocular NeovascularizationArchives of Ophthalmology (1950), 1988
- Ocular Neovascularization With Retinal Vascular OcclusionArchives of Ophthalmology (1950), 1982
- Inhibition of Cell Motility by InterferonScience, 1980
- Tumor Angiogenesis: Iris Neovascularization at a Distance From Experimental Intraocular Tumors2JNCI Journal of the National Cancer Institute, 1973